Amylyx Pharmaceuticals Inc (AMLX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 226,651 | 225,178 | 58,085 | 59,764 | 77,391 |
| Marketable Securities | 90,328 | 118,812 | 122,741 | 144,304 | 99,110 |
| Receivables | 88 | 132 | 103 | 300 | 447 |
| TOTAL | $323,671 | $353,383 | $186,890 | $216,144 | $189,432 |
| Non-Current Assets | |||||
| PPE Net | 310 | 399 | 445 | 816 | 961 |
| Other Non-Current Assets | 8,664 | 8,959 | 7,263 | 2,716 | 3,241 |
| TOTAL | $8,974 | $9,358 | $7,708 | $3,532 | $4,202 |
| Total Assets | $332,645 | $362,741 | $194,598 | $219,676 | $193,634 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,519 | 5,339 | 3,294 | 4,810 | 2,939 |
| Accrued Expenses | 17,910 | 19,471 | 17,465 | 12,067 | 23,949 |
| TOTAL | $22,688 | $25,791 | $21,424 | $17,932 | $28,406 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 4,698 | 4,954 | 5,297 | 327 | 463 |
| TOTAL | $4,698 | $4,954 | $5,297 | $327 | $463 |
| Total Liabilities | $27,386 | $30,745 | $26,721 | $18,259 | $28,869 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 110,537 | 109,820 | 89,167 | 89,141 | 88,602 |
| Common Shares | 11 | 11 | 9 | 9 | 7 |
| Retained earnings | -751,427 | -718,428 | -684,042 | -642,599 | -606,692 |
| Other shareholders' equity | 404 | 815 | 551 | 0 | -92 |
| TOTAL | $305,259 | $331,996 | $167,877 | $201,417 | $164,765 |
| Total Liabilities And Equity | $332,645 | $362,741 | $194,598 | $219,676 | $193,634 |